Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs.

Select a country profile

Fact Sheet

Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

Policy Analysis

The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

Policy Analysis

Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

1 in 3

pregnant women in the developing world living with HIV receive no antiretroviral medication

6.6_M

women in developing regions have an unmet need for antiretroviral therapy

$1.00

the annual per capita cost to meet the need for essential adolescent sexual and reproductive health services

Resources

Explore the Data Center

Hear from an expert

The evidence strongly indicates that providing women with effective new tools to simultaneously prevent unwanted pregnancy as well as protect against STIs and HIV is essential. However, just developing these methods is not enough. They need to be designed and marketed in a way that meets the needs and respects the rights of women and their partners. Ultimately, multipurpose prevention technologies (MPTs) will be viable options only if women actually use them

Heather D. Boonstra

Vice President for Public Policy